S 1852
118th Congress
Senate
Health
Blood and blood diseases
Genetics
Health promotion and preventive care
Hereditary and development disorders
Medical research
Research administration and funding
Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2023
Everywhere this bill has been
5 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Sep 6, 2023
Placed on Senate Legislative Calendar under General Orders. Calendar No. 201.
Sep 6, 2023
Committee on Health, Education, Labor, and Pensions. Reported by Senator Sanders without amendment. Without written report.
Jun 15, 2023
Committee on Health, Education, Labor, and Pensions. Ordered to be reported without amendment favorably.
Jun 7, 2023
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Jun 7, 2023
Introduced in Senate
Plain-English summary
Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2023
This bill reauthorizes through FY2028 the Sickle Cell Disease Treatment Demonstration Program, which supports efforts to improve treatment and prevention of sickle cell disease and complications from that disease. (Sickle cell disease is an inherited blood disorder that can lead to pain, anemia, infections, and stroke.)
What's happening now
Placed on Senate Legislative Calendar under General Orders. Calendar No. 201.
Committees of jurisdiction
1